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RECFNT experience has shown that many of the growth-inhibiting agents
used in the palliative treatment of cancer are carcinogenic. They also cause
specific damage to cell nuclei and chromosomes and are able to induce mutations.
The association of these biological effects of (1) growth inhibition, (2) chromo-
some damage, (3) production of mutations and (4) induction of cancer suggests
that they may have a common fimundamental biochemical mechanism. If the
induction of cancer is indeed a somatic mutation, then cancer induction might
be included as a special mutation. The fact that X-rays can produce cancer in
man was published in 1902 (Frieben, 1902), seven years after Rontgen's discovery
of X-rays. Muiiller (1928) found that X-rays are mutagenic, and later Mather
and Stone (1933) and Koller (1934) described the chromosome damage following
irradiation. The idea that cancer arises as a somatic mutation was supported
by the demonstration of an increased incidence of mutations occurring in mice
treated with chemical carcinogens. This was shown with methylcholanthrene
by Strong (1945) and with 1:2:5:6-dibenzanthracene by Carr (1947). The
carcinogenic hydrocarbons inhibit the growth of animals and the establishment
and growth of transplanted tumours (Haddow, Scott and Scott, 1937). They
are able to cause breaking of chromosomes in tumour cells (Koller, personal
communication). One of the most potent carcinogenic hydrocarbons, 9:10-
dimethyl-1:2-benzanthracene, has been used with some temporary success in the
treatment of lymphocytic leukaemia (Engelbreth-Holm and Stamer, 1947).
In the treatment ofleukaemia (Paterson, ApThomas, Haddowand Watkinson,
1946), urethane has been used as an alternative to radio-therapy. This drug
also induces cancer of the lung in mice (Nettleship and Henshaw, 1943) and
inhibits mitosis (Dustin, 1947). Derivatives of 4-dimethylaminostilbene also
have this dual action. These compounds were first foundto begrowth inhibitors,
and later found to be potent carcinogens (Haddow, Harris, Kon and Roe, 1948).INDUCTION OF TUMOURS WITH NITROGEN MUSTARDS
The vesicants, mustard gas (di(2-chloroethyl)sulphide) and nitrogen mustards
(e.g. methyl di(2-chloroethyl)amine, HN2 and tri(2-chloroethyl)amine HN3)
cause increased stickiness of chromosomes and rupture of chromosomes (Darling-
ton and Koller, 1947; Boyland, Clegg, Koller, Rhoden and Warwick, 1948).
They also produce mutations, as was shown in drosophila by Auerbach and
Robson (1947) and in neurospora by Horowitz, Houlahan, Hungate and Wright
(1946) and by Tatum (1947). The numerous other radiomimetic actions of the
nitrogen mustards, which have been discussed elsewhere (Boyland, 1948), show
the remarkable similarity in action of vesicants and radiations. Mustard gas
was shown to have an anticarcinogenic action by Berenblum (1931), and this
antagonistic action may be similar to the antagonism of weak carcinogens to
potent carcinogens described by lacassagne, Buu-Hoi and Cagniant (1944).
By analogy with previous findings the nitrogen mustards might be expected to
have carcinogenic action,andthe actualinduction oftumours by these substances
is described in the present paper.
EXPERIMENTAL.
Two groups each of 20 stock mice were given weekly subcutaneous injections
of 10 ml. per kg. body-weight of freshly made aqueous solutions of nitrogen
mustard. The first group was given methyl di(2-chloroethyl)amine hydro-
chloride (HN2) in a concentration of 1 mg. per 10 ml., so that it received
1-0 mg. per kg. body-weight at weekly intervals for 50 weeks. The second group
received the same dose of tri(2-chloroethyl)amine hydrochloride (HN3) for 10
weeks, after which time only 4 mice remained alive and injections were stopped.
Post-mortem findings of the mice which died within a week of an injection
usually showed congestion ofthe alimentary tract or lungs. With the doses used
no nervous symptoms were seen. All the coloured mice showed the effect of
greying of hair (Boyland et al., 1948) similar to that produced by X-rays (Hance
and Murphy, 1926) or by subcutaneously implanted plutonium (Prosser, Painter,
Lisco, Brues, Jacobson and Swift, 1947). The de-pigmented area of fur usually
became visible at the site of injection after 2 or 3 weeks. Other experiments
have shown that intradermal injection of the nitrogen mustard is more effective
than subcutaneous injection in producing this effect on hair colour.
Delayed effects of treatment.
Differential blood counts were made on the surviving mice 15 months after
the beginning of the injections. Three of the HN2 series (No. 16, 18 and 19)
and three of the HN3 series (No. 38, 39 and 40) were leucopenic. The blood
picture was abnormal (Table I) in showing a deficiency oflymphocytes. Cameron,
Courtice and Jones (1947) found that injection of IHN2 into rabbits and dogs
caused neutropenia and lymphocytopenia. The present results indicate that
the repeated injection of nitrogen mustards induces a chronic lymphocytopenia
in a proportion of treated mice.
One mouse (No. 10) which died 148 days after beginning of treatment with
HN2 showed (1) slight proliferation of the bronchiolar epithelium, (2) mobiliza-
tion oflymphocytes round ducts and bloodvessels ofthe liver, and (3) aggregation
of lymphocytes around bronchioles and blood vessels of the lung.
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TABLE I.-Blood Counts of Mice made 13 Months after Commeneme
of Treatment.
Mice No. 14-20 treated with HN'2.
Mice No. 37-40 treated with HN3.
Differential count of per cent oftotal
Mouse R.B.C. count ]fb o Total ieutro- E nco- i-
No. in mflions. (Haldane). leucocytes. phil Lympho- Mono- Eosino- fled No. inmmill}ons. (Haldane). lecocyte poly- cytes. cytes. phils. immature
morphs. cells.
14. . 6-4 . 44 .46,400 . 66 31 1 .. 2
15 . . . 7 - 3 . 72 . 46,400 . 70 24 1 .. 5
16 . . 3-*3 . 38 . 10,000 . 30 66 .. .. 4
17 . . . 7 - 3 . 73 . 8,000 . 35 62 3 .. ..
18 . . . 9- 2 . 88 . 16,000 . 45 50 5 . .
19 . . . 10-1 . 96 . 12,600 . 44 52 3 1 . .
20 . . . 10- 6 . 103 . 14,600 . 60 38 2 . .
37 . . . 101 . 110 . 18,400 . 41 53 1 .. 5
38 . . 11-9 . 110 . 9,400 . 58 41 .. . 1
39 . . 10- 5 . 108 . 6,000 . 32 67 1 .. ..
40 . . . 9- 8 . 94 . 5,600 . 39 69 2 .. ..
Untreated (mean
of 20 mixed
stock mice) . 10-2 . 103 . 19,000 . 17 79 2 1 1
The post-mortem findings in mice which survived more than 280 days are
shown in Tables II and III. Of the total of 14 mice, 10 had tumours, including
lung carcinomas and adenomas in 8, lymphosarcomas in 2, a uterine fibromyoma
and a sarcoma at the site of injection. Of the mice free of neoplasms 2 had
lymphocytic infiltration of the liver and lung and 2 had abnormal proliferation
of the bronchiolar epithelium. Most of the mice with lung tumours or lympho-
sarcomas in the liver had enlarged lymph nodes.
A group of 40 untreated mice from the same source as the experimental mice
were killed when between 14 and 18 months of age. In this series 6 mice had
adenomas ofthe lung, 2 hepatomas and 3 had enlarged lymph nodes.
The mice with lymphosarcomas had greatly enlarged livers (Fig. 1), in which
the normal structure was destroyed (Fig. 2), the malignant cellsshowingnumerous
mitoses (Fig. 3).
The lung tumours were for the most part larger and more malignant (Fig. 4
and 5) than those occurring spontaneously in mice. Many ofthese lung tumours
DESCRIPTION OF PLATES.
FIG. 1.-Mouse 12 (decapitated). Treated for 347 days with HN2. This rodent developed
a lymphosarcoma in the liver, together with enlarged thymus and lymph nodes. Macro-
scopic lesions can be seen in liver. x l1.
FIG. 2.-Lymphosarcoma; section of liver of mouse seen in Fig. 1. x 105.
FIG. 3.-Mouse 40. Subcutaneous spindle-celled sarcoma which developed at site ofinjection
with HN3. x 210.
FIG. 4.-Mouse 15. Showing dense aggregation of lymphocytes around bronchioles in lung
following treatment with HN2. x 58.
FIG. 5. Mouse 17. Adenocarcinoma of lung following treatment with HN2. x 105.
FIG. 6. Mouse 38. Carcinoma of hmg following treatment with HN3. Tumour cells are
seen invading the alveclar tissue ofthe lung. x 210.
FIG. 7.--Same as Fig. 6. Showing another field in the same section, in which the lumen
of a bronchiole is occluded by tunour cells. x 210.
FIG. 8.-Mouse 19. Treated with HN2. Carcinoma of lung. X 210.BRITmSH JouRNAL OF CANCER.
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TABLE II.-Mice Injected with Weekly Doses of 1-0 mg./kg. of Methyl Di-(2-chloro-
ethyl)amine HydrocMhloride (HN2) till Death orfor 50 Weeks.
Survival Mouse time Post-mortem findings.
(days).
10 . 148 . Proliferation of bronchiolar epithelium with aggregation of lymphocytes
round ducts and vessels of liver.
11 . 284 . Lung, adenoma.
12 . 347 . Liver, lymphosarcoma with dense lvmphocytic infiltration and cell de-
generation. Lymph nodes and thymus greatly enlarged.
13 . 367 . Lung, proliferation of bronchioles; early bronchogenic tumnours and thicken-
ing of interalveolar septa.
14 . 398 . Liver, slight lymphocytic infiltration.
Lung, abscess, destruction of alveoli, dense lymphocytic infiltration with
polymorphs.
15 . 399 . Liver, marked lymphocytic infiltration.
Lung, thickening of interalveolar septa.
16 . 550 . Uterus fibromyoma.
Lung, proliferation of bronchiolar epithelium with fibrosis and internal
infiltration of lymphocytes in blood vessel.
17 . 569 . Lung, carcinoma accompanied by dense lymphocytic infiltration.
Liver, slight lymphocytic infiltration accompanied by degeneration of liver
cells.
Spleen, thymus and lymph nodes enlarged.
18 . 569 . Lung, carcinoma with aggregation of lymphooytes around blood vessels and
bronchioles.
Prostate, hypertrophy of prostatic epithelium, not so pronounced as in
No. 40.
Lymph nodes enlarged.
19 . 575 . Lung, carcinoma.
20 . 580 . Liver, marked lymphocytic infiltration around blood vessels and ducts.
TABLE III.-Mice Injected with 10 Doses of 1-0mg./kg. of Tri-(2-chloroethyl)amine
Hydrochloride (HN3) which Surrived More than 54 Days.
Survival No.s time Post-mortemfinding Nso. (days).
37 . 548 . Lung adenoma with lymphocytic infiltration.
38 . 952 . Lung, bronchogenic carcinoma infiltrating alveolar tissue.
39 . 560 . Lung, bronchiolar proliferation.
Kidney, glomerulonephritis.
40 . 567 . Lung, carcinoma.
Spindle-celled sarcoma at site of injection.
Prostate, pronounced hypertrophy of epithelium in anterior lobe.
Liver, lymphocytes around duct.
Thymus, lymnph ncdes and parctid enlarged.
were invading the normal tissue, and in many cases the lungs of these mice had
aggregations oflymphocytes.
The spindle-celled sarcoma at the site of injection of mouse No. 40 was still
small when the mouse was killed, and was immediately below the area of de-
pigmented skin where injections had been made.
DISCUSSION.
The results of the experiments suggest that the nitrogen mustards have a
slow carcinogenic action. As only 14 mice survived to an age when tumours
occur the experiments are being extended in mice ofpure strains. The incidence
of lung tumours and lymphosarcomas was higher than would be expected to
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occur spontaneously, and the tumours were larger and more malignant than
those generally encountered in untreated mice.
The carcinogenic action of the nitrogen mustards is very slow, the earliest
lung tumour and lymphosarcoma being seen at 284 and 347 days respectively.
Berenblum and Shubik (1947) have shown that carcinogenesis can be divided
into an initial stage in which cells are irreversibly changed into latent tumrnour
cells, and a development stage which can be brought aboutbycocarcinogenssuch
as croton oil. The incidence oftumours expressed as quantalresponse isprobably
dependent on the initiating action, but the rate of appearance of the tumours
depends upon cocarcinogenic action.
The present authors consider that the initial irreversible conversion to latent
tumour cells is the change which is associated with chromosome damage and
mutations. The nitrogen mustards are possibly active in initiating the carcino-
genic change but poor in developing action. In order to test this hypothesis
experiments are in hand in which mice are being treated with nitrogen mustard
and croton oil.
A possible explanation of the association between inhibition of growth and
carcinogenic power is that the inhibition is due to interference with cell division
in growing tissues. The drugs under discussion reduce the rate of growth by
impeding mitosis. This interference with mitosis is likely to increase the chances
of a somatic mutation from normal to malignant cells occurring. The somatic
mutation is possibly a relatively rare event, the occurrence of which is more
probable when the difficulties of cell division are increased either by radiations
or by chemical agents.
SUMMARY.
MNice were given weekly subcutaneous injections of nitrogen mustards. Of
14 mice which survived more than 250 days, 10 had tumours including lung
tumours (8), lymphosarcomas (2), a uterine fibromyoma and a spindle-celled
sarcoma at site of injection.
This investigation has been supported by grants to The Royal Cancer Hospital
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THE investigation of carcinogenic substances which have been obtained
from human tissues (Kleinenberg, Neufach and Shabad, 1940) and from other
biological sources has been the subject of earlier publications from this Institute
(Hieger, 1940, 1941, 1946, 1947), reporting that:
1. A carcinogen is present in extracts from human subjects who have
died of cancer or ofother causes.
2. The carcinogen is found in the unsaponifiable part of a number of
tissues, such as liver, lung, kidney and muscle.
3. It is found in the cholesterol-rich part ofthe unsaponifiable fraction,
which contains c. 85 per cent of the digitonin precipitable sterol and is
referred to below as "Fraction A" or "Stage A," or "- 10° fraction,"
since it crystallizes out at - 10° when the unsaponifiable fraction of the
tissue (doubly saponified) is crystallized from methyl alcohol.
4. Commercial cholesterol containing 95-98 per cent of the pure sterol
is carcinogenic, and its potency is of the same order as that of the active
fractions from human tissues.
With very few exceptions the carcinogen in biological material is slow acting
(Table V), by comparison with synthetic carcinogens. Hence the tests on
animals are lengthy.
Since some ofthe experiments described here were in progress when the papers
referred to above were published and others have not before been described in
detail, a certain amount of repetition is unavoidable.